Pasar Laboratorium Klinik Indonesia diperkirakan akan tumbuh pada CAGR besar-besaran sebesar 12,5% selama 2021-2026 memberikan peluang yang menguntungkan bagi investor: Ken Research

Buy Now

• Laboratorium Pemisahan Spektrometri Massa, Laboratorium Patologi Anatomi, dan Laboratorium Imunologi Lanjut adalah beberapa laboratorium yang akan menjadi tren untuk generasi selanjutnya
• Diperkirakan bahwa pasar akan terkonsolidasi dengan lebih banyak pemain yang memasuki pasar. Pemain diagnostik akan terus menambahkan layanan tes laboratorium dan penilaian hasil yang lebih kompleks dan detail dalam upaya untuk membedakan keunggulan antar pemain. Konsolidasi potensial dalam industri, akan memberikan daya tarik yang mendorong pertumbuhan.
• Pertumbuhan pendapatan tes esoterik akan memiliki nilai keuntungan yang lebih tinggi dan didorong oleh peningkatan jumlah rujukan dari rumah sakit umum, laboratorium, dan rumah sakit swasta yang belum memiliki fasilitas untuk melakukan tes esoterik.

Pelaksanaan Jaminan Kesehatan Nasional (JKN): Penerapan JKN diharapkan dapat meningkatkan permintaan terhadap layanan laboratorium. Hal ini akan mengarahkan rumah sakit umum untuk merujuk sampel ke laboratorium independen swasta untuk pengujian klinis, yang menghasilkan pertumbuhan rujukan eksternal untuk laboratorium independen swasta.

Peningkatan Investasi: Para pemain diharapkan dapat meningkatkan investasi, kemampuan pengujian dan mengadopsi beberapa pengujian dengan teknologi canggih yang akan diperkenalkan di pasar global, khususnya pengujian yang lebih spesifik.

Ekspansi Wilayah Geografis:  Selanjutnya, jangkauan rantai laboratorium independen swasta besar diharapkan melakukan ekspansi geografis di luar kota-kota utama ke daerah-daerah kota kedua, ketiga, dan seterusnya. Hal tersebut selanjutnya akan diperkirakan mengarah pada peningkatan pangsa pasar di pasar laboratorium klinis Indonesia secara keseluruhan.

Peningkatan Kewaspadaan sebagai dampak COVID-19: Keberadaan Covid-19 meningkatkan kesadaran masyarakat terhadap sistem dan kualitas kesehatan di Indonesia. Meskipun pengeluaran rumah tangga turun -2,23% YoY di Q1-2021 (vs 2,83% YoY di Q1-2020), komponen kesehatan dan pendidikan tumbuh sebesar 0,31% YoY di Q1-2021, atau salah satu dari dua komponen yang mengalami peningkatan di Q1-2021.

Laporan berjudul “Prospek Pasar Laboratorium Klinik Indonesia hingga 2026F- Didorong oleh ketersediaan laboratium yang ada  saat ini, perluasan basis pelanggan dan peningkatan persyaratan perusahaan untuk pengujian klinis” memberikan analisis komprehensif tentang Pasar Laboratorium Klinik di Indonesia. Laporan ini berfokus pada ukuran pasar secara keseluruhan dalam hal pendapatan yang dihasilkan oleh laboratorium; Segmentasi pasar laboratorium klinik Indonesia berdasarkan Jenis Lab Mandiri, jenis pembayar, jenis pelanggan, jenis tes, segmentasi berdasarkan wilayah dan rumah sakit swasta. Laporan ini juga mencakup lanskap komparatif secara keseluruhan, tren dan pendorong pertumbuhan, masalah dan tantangan serta peraturan pemerintah. Laporan ini diakhiri dengan proyeksi masa depan dan rekomendasi analis yang menyoroti peluang dan peringatan utama.

Segmen Utama yang Tercakup dalam Pembahasan Laporan 

Berdasarkan Jenis Laboratorium

Laboratorium Independen

Laboratorium Rumah Sakit Swasta

Laboratorium Rumah Sakit Umum/Publik

Berdasarkan Jumlah Laboratorium

Laboratorium Swasta

Laboratorium Umum/ Publik

Berdasarkan Jenis Laboratorium Swasta Independen:

Terorganisir

Tak Terorganisir

Berdasarkan Tipe Penganggung Pembiayaan:

Pembiayaan oleh Perusahaaan tempat Bekerja

Pembiayaan Pribadi

Asuransi Kesehatan Pribadi

BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)

Berdasarkan Tipe Pelanggan / Pengunjung:

Rujukan Dokter

Perusahaan

Datang secara Langsung

Rujukan Eksternal

Referensi Online

Berdasarkan Jenis Tes :

Tes Rutin

Tes Esoteric

Tes Non-Laboratorium

Berdasarkan Jenis Tes Rutin:

CBC

Panel Metabolik Dasar

A1C

Lainnya

Berdasarkan Jenis Tes Esoterik

Endocrine

Penyakit Menular

Penyakit Alergik

Onkologi

Lainnya

Berdasarkan Tipe Laboratorium Rumah Sakit Swasta

In-House

Pihak Ketiga

Berdasarkan Wilayah

Jabodetabek

Jawa Barat

Jawa Timur, Bali, Nusa Tenggara

Aceh dan Sumatera Utare

Jawa Tengah

Pu;au Sumatera wilayah Tengah

Sulawesi and Maluku

Kalimantran

Lainnya

Narasumber Utama

Perusahaan Laboratorium Klinik

Laboratorium Klinik Terorganisir

Laboratorium Klinik yang Tidak Terorganisir

Rumah Sakit Swasta

Investor (Ekuitas Swasta dan Modal Ventura)

Asosiasi Industri

Penyedia teknologi

Periode Waktu yang Tercatat dalam Laporan:

Periode Waktu secara Historis – 2016-2021

Periode Waktu Proyeksi Pasar – 2021-2026

Daftar Perusahaan Laboratorium yang Tercakup pada Laporan:

Perusahaan Laboratorium Terorganisir:

Prodia

Diagnos

Pathlab

Pramita

Ultra Medica

Kimia Farma

Prima Medika

Cito

Parahita

ABC Labs

Bio Medika

Topik Utama yang Dicakup dalam Laporan

Tinjauan Pasar Laboratorium Klinik Indonesia

Ekosistem Entitas Utama di Pasar Laboratorium Klinik Indonesia

Siklus Bisnis dan Asal Mula Pasar Laboratorium Klinik Indonesia

Ukuran Pasar Laboratorium Klinik Indonesia, 2016-2021

Segmentasi Pasar Laboratorium Klinik Indonesia

Analisis Persaingan: Perusahaan Laboratorium Klinik Indonesia

Analisis SWOT di Pasar Laboratorium Klinik Indonesia

Penggerak dan Penghambat Pertumbuhan di Pasar Laboratorium Klinik Indonesia

Kemajuan Teknologi di Pasar Laboratorium Klinik Indonesia

Dampak COVID19 di Pasar Rahasia Properti Malaysia

Tren Utama di Pasar Laboratorium Klinik Indonesia

Prospek dan Proyeksi Masa Depan untuk Pasar Laboratorium Klinik Indonesia

Rekomendasi / Faktor Keberhasilan

Metodologi Penelitian

Lampiran

Hubungi Kami:

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Indonesia Clinical Laboratory Market is expected to grow at a massive CAGR of 12.5% during 2021-2026 providing a lucrative opportunity for investors: Ken Research

 Buy Now

• Mass Spectrometry & Separation Science Laboratory, Anatomical Pathology Laboratory, Advance Immunology Laboratory are some of the next generation laboratories.
• Market is expected to consolidate with more players entering the market. Diagnostics players will continue to add complex tests and assessments in a bid to differentiate. Potential consolidation in the industry, would provide tailwinds to the growth.
• The revenue growth of esoteric tests will be supported by higher margins and increase in number of referrals from public hospitals, laboratories and private hospitals without facilities to perform esoteric tests.

Implementation of JKN: It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories.

Increase in Investment: Players are expected to increase investment, testing capabilities and adopt several advanced tests and technologies which will be introduced in the global market, particularly specialized tests.

Indonesia Healthcare Market

Geographical Expansion: Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market.

Increased Awareness due to COVID-19: The existence of Covid-19 raises public awareness of the health system and quality in Indonesia. Although household spending decreased by -2.23% YoY in 1Q21 (vs 2.83% YoY in 1Q20), the health and education component grew by 0.31% YoY in 1Q21, or one of the two components that saw an increase in 1Q21.

The report titled “Indonesia Clinical Laboratory Market Outlook to 2026F- Driven by current shortage, widening customer base and increasing corporate requirements for clinical testing” provides a comprehensive analysis of Clinical Laboratory Market in Indonesia. The report focuses on overall market size in terms of revenue generated by laboratories; Indonesia clinical laboratory market segmentation by Type of Independent Labs, type of payer, type of customers, types of tests, segmentation based on region and private hospitals. The report also covers the overall comparative landscape, trends and growth drivers, issues and challenge and government regulations. The report concludes with future projections and analyst recommendations highlighting the major opportunities and cautions.

Key Segments Covered of Clinical Laboratory: -

By Type of Labs

Independent Labs

Private Hospital Labs

Public Hospital Labs

By Number of Labs

Private Labs

Public Labs

By Type of Private Independent Labs:

Organised

Unorganised

By Type of payor:

Corporates

Out-Of-Pocket

Private Insurance

BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)

By Type of Customer:

Doctor Referral

Corporates

Walk-Ins

External referrals

Online Referrals

By Type of Tests:

Routine

Esoteric

Non-Laboratory

By Type of routine tests:

CBC

Basic Metabolic Panel

A1C

Others

By Type of Esoteric Tests

Endocrine

Infectious disease

Allergic Disease

Oncology

Others

By Private Hospital Labs

In-House

Third Party

By Region

Greater Jakarta

West Java

East Java, Bali, Nusa

Aceh and North Sumatera

Central Java

Central Sumatera

Sulawesi and Maluku

Kalimantran

Others

Request for Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTI0MDQ5

Key Target Audience

Clinical Laboratory companies

Organised Clinical Laboratories

Unorganised Clinical Laboratories

Private Hospitals

Private Equity and Venture Capitalist

Industry Associations

Technology providers

Time Period Captured in the Report:

Historical Period – 2016-2021

Forecast Period – 2021-2026

Companies Covered:

Organised Laboratory Companies:

Prodia

Diagnos

Pathlab

Pramita

Ultra Medica

Kimia Farma

Prima Medika

Cito

Parahita

ABC Labs

Bio Medika

Key Topics Covered in the Report

Overview of Indonesia Clinical Laboratory Market

Ecosystem of Major Entities in Indonesia Clinical Laboratory Market

Business Cycle and Genesis of Indonesia Clinical Laboratory Market

Indonesia Clinical Laboratory Market Size, 2016-2021

Indonesia Clinical Laboratory Market Segmentations

Competition Analysis: Indonesia Clinical Laboratory Companies

SWOT Analysis in Indonesia Clinical Laboratory Market

Growth Drivers and Restraints in Indonesia Clinical Laboratory Market

Technological Advancements in Indonesia Clinical Laboratory Market

Impact of COVID19 in Malaysia Property Classified Market

Key Trends in Indonesia Clinical Laboratory Market

Outlook and Future Projections for Indonesia Clinical Laboratory Market

Recommendations / Success Factors

Research Methodology

Appendix

For More Information on the Research Report, refer to below links: –

Indonesia Clinical Laboratory Market

Related Reports by Ken Research

Brazil Diagnostic Labs Market Outlook to 2025

Vietnam Clinical Laboratory Market Outlook to 2022

Contact Us: -

Ken Research

Ankur Gupta, Head Marketing & Communications

support@kenresearch.com

+91-9015378249

Follow Us

LinkedIn | Instagram | Facebook | Twitter | YouTube

Indonesia Healthcare Market Outlook to 2022: Ken Research

 Buy Now

The Healthcare industry comprise of medical insurance, hospitals, pharma industry, medical tourism, diagnostic services and others. The healthcare industry basically consists of maintenance or the improvement of health treatment, diagnosis, recovery, or curing of disease, injury, illness, and other physical & mental treatments. The health care services are delivered by health professionals. The healthcare service includes a combination of tangible & intangible services. The intangible services are completely offered by the doctor while the tangible services such as bed and decor. The Indonesia one of key countries where the healthcare spends is considerably rising at a rapid pace. Moreover, Indonesia’s healthcare industry provides a productive investment opportunity to the foreign-investors towards all aspects of the industry, ranging from the hospitals to pharmaceuticals to the medical devices.

Indonesia Healthcare Market is segmented by pharmaceutical market, medical devices market, hospitals market, pharmacy retail market, clinical laboratory market and others. Pharmaceutical market is further segmented by domestic & international players, by therapeutic segment and generic & patented drugs. Medical devices market is further segmented by procurement and by type of medical devices. Hospital market is further segmented by general & specialty hospitals. Pharmacy retail market is further segmented by pharmacies & drugstores. Additionally, clinical laboratory market is further segmented by type of private independent laboratory, by type of laboratory and type of tests in private independent laboratory.

Demand for different healthcare services in the country has increased over the past years on account of increase in prevalence of various lifestyle-related diseases for instance Hypertension, Diabetes, Obesity, Cardiovascular diseases, Blood Pressure, and expanding population base of the country has cemented the polyclinic market’s position as major healthcare service provider in the country. Majority of people in Indonesia country have preferred polyclinics over the hospitals in the past years owing to convenience & lower cost of healthcare service. The expansion of private and public hospitals and clinics along with the improvement of existing facilities has driven demand for medical products.

The Indonesia Healthcare Industry is driven by increase in investment in healthcare industry, followed by growth in population, favorable macroeconomic environment, rise in foreign investments, increase in disposable income, growth in supportive government policies and increase in hospitals & clinics. Apart from this, low bed to population ratio and shortage of qualified staff may impact the market. Investors are expected to work closely with reliable medical schools and vocational schools, and expected to provide access to quality equipment and training. The hospitals are further encouraged to allow professionals to work in clinics/hospitals designed to provide opportunity to various skills and experience. Moreover, economy is registering a continuous growth however there may be some variations of distribution of health care services between urban and rural areas. In order to cater the rising demand of healthcare services and better access towards the hospital services for the rural population.

It is predicted that future of the Indonesia Healthcare Market Research Report will be bright because of increase in focus on research and development for pharmaceutical products, growth in innovation in pharmaceutical manufacturers & clinical laboratory services, increase in healthcare facilities, and expansion of pharmacy retail chains during the forecast period.

Key Topics Covered in the Report: -

Indonesia Healthcare, Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Size, 2012-2017

Indonesia Hospitals Market Segmentation (by public & private hospitals, by general & specialty hospitals and by region)

Indonesia Hospitals, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Market Competitive Landscape

Indonesia Hospital, Pharmaceutical, Pharmacy Retail, Clinical Laboratory, Medical Devices Future Outlook and Projections, 2018-2022

Indonesia Pharmaceuticals Market Segmentation (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region)

Indonesia Pharmacy Retail Market Segmentation (by pharmacies & drugstores and by region)

Indonesia Clinical Laboratory Market Segmentation (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region)

Indonesia Medical Devices Market Segmentation (by type of medical device, by type of medical consumables, by end-user and by procurement)

Analyst Recommendations

Macro-economic Factors Impacting Indonesia Healthcare Market

For More Information on the Research Report, refer to below links: -

Indonesia Healthcare Market Research Report

Related Report:-

Indonesia Health Tech Market Outlook to 2025-Lack of Medical Staff and Protective Gear to Lean on Healthcare Startups in Indonesia

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249